Arcadia Biosciences Inc
RKDA3.040USD
-0.170-5.30%
收盘 12/24, 13:00（美东）报价延迟15分钟
4.16M总市值
亏损市盈率 TTM
关于 Arcadia Biosciences Inc 公司
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
Arcadia Biosciences Inc简介
公司代码RKDA
公司名称Arcadia Biosciences Inc
上市日期May 15, 2015
CEOSchaefer (Thomas J)
员工数量9
证券类型Ordinary Share
年结日May 15
公司地址5956 Sherry Lane
城市DALLAS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编75225
电话12149748921
网址https://arcadiabio.com/
公司代码RKDA
上市日期May 15, 2015
CEOSchaefer (Thomas J)
Arcadia Biosciences Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Interim Chief Financial Officer
President, Chief Executive Officer, Interim Chief Financial Officer
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Deborah D. (Debbie) Carosella
Ms. Deborah D. (Debbie) Carosella
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Thomas J. Schaefer
Mr. Thomas J. Schaefer
President, Chief Executive Officer, Interim Chief Financial Officer
President, Chief Executive Officer, Interim Chief Financial Officer
--
--
Dr. Albert D. Bolles, Ph.D.
Dr. Albert D. Bolles, Ph.D.
Independent Director
Independent Director
--
--
Ms. Lilian Shackleford Murray
Ms. Lilian Shackleford Murray
Independent Director
Independent Director
--
--
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
--
--
Ms. Amy J. Yoder
Ms. Amy J. Yoder
Independent Director
Independent Director
--
--
Mr. Kevin J. Comcowich
Mr. Kevin J. Comcowich
Independent Chairman of the Board
Independent Chairman of the Board
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由于公司未披露，未能获取相关数据
地区USD
名称
营收
占比
United States
4.90M
97.19%
Canada
109.00K
2.16%
Argentina
26.00K
0.52%
India
7.00K
0.14%
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.95%
Mariner Wealth Advisors
0.89%
State Street Investment Management (US)
0.88%
DRW Securities, LLC
0.73%
其他
95.52%
持股股东
持股股东
占比
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.95%
Mariner Wealth Advisors
0.89%
State Street Investment Management (US)
0.88%
DRW Securities, LLC
0.73%
其他
95.52%
股东类型
持股股东
占比
Investment Advisor
2.73%
Investment Advisor/Hedge Fund
1.83%
Individual Investor
0.82%
Hedge Fund
0.12%
Research Firm
0.08%
其他
94.42%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
30
58.96K
4.31%
-249.34K
2025Q2
35
87.93K
6.43%
-234.13K
2025Q1
38
87.93K
6.43%
-244.41K
2024Q4
49
156.69K
11.48%
-110.76K
2024Q3
49
100.21K
9.85%
-202.17K
2024Q2
47
71.82K
7.77%
-229.97K
2024Q1
51
258.53K
25.32%
-38.12K
2023Q4
56
321.69K
30.80%
+98.94K
2023Q3
62
165.26K
19.23%
-273.71K
2023Q2
66
255.84K
27.41%
-81.95K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
14.04K
1.03%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
12.79K
0.94%
--
--
Jun 30, 2025
Mariner Wealth Advisors
14.50K
1.06%
-12.98K
-47.24%
Jun 30, 2025
State Street Investment Management (US)
12.15K
0.89%
--
--
Jun 30, 2025
Jacot (Stanley Jr)
5.00K
0.37%
--
--
Mar 31, 2025
Schaefer (Thomas J.)
2.82K
0.21%
--
--
Mar 31, 2025
Kawakami (Mark)
2.68K
0.2%
--
--
Mar 31, 2025
Tower Research Capital LLC
1.92K
0.14%
+1.48K
+338.22%
Jun 30, 2025
UBS Financial Services, Inc.
2.51K
0.18%
-6.02K
-70.57%
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
公告日期
类型
比率
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
Feb 28, 2023
Merger
40→1
常见问题
Arcadia Biosciences Inc的前五大股东是谁？
Arcadia Biosciences Inc 的前五大股东如下：
The Vanguard Group, Inc.持有股份：14.04K，占总股份比例：1.03%。
Geode Capital Management, L.L.C.持有股份：12.79K，占总股份比例：0.94%。
Mariner Wealth Advisors持有股份：14.50K，占总股份比例：1.06%。
State Street Investment Management (US)持有股份：12.15K，占总股份比例：0.89%。
Jacot (Stanley Jr)持有股份：5.00K，占总股份比例：0.37%。
The Vanguard Group, Inc.持有股份：14.04K，占总股份比例：1.03%。
Geode Capital Management, L.L.C.持有股份：12.79K，占总股份比例：0.94%。
Mariner Wealth Advisors持有股份：14.50K，占总股份比例：1.06%。
State Street Investment Management (US)持有股份：12.15K，占总股份比例：0.89%。
Jacot (Stanley Jr)持有股份：5.00K，占总股份比例：0.37%。
Arcadia Biosciences Inc的前三大股东类型是什么？
Arcadia Biosciences Inc 的前三大股东类型分别是：
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Mariner Wealth Advisors
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Mariner Wealth Advisors
有多少机构持有Arcadia Biosciences Inc(RKDA)的股份？
截至2025Q3，共有30家机构持有Arcadia Biosciences Inc的股份，合计持有的股份价值约为58.96K，占公司总股份的4.31%。与2025Q2相比，机构持股有所增加，增幅为-2.12%。
哪个业务部门对Arcadia Biosciences Inc的收入贡献最大？
在FY2024，--业务部门对Arcadia Biosciences Inc的收入贡献最大，创收--，占总收入的--%。
